Lansforsakringar Fondforvaltning AB (publ)
Position in NTRA — Natera, Inc.
CIK 2059323
Stockholm, V7
Position in NTRA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$11,015,441
+$3,040,640 QoQ
Shares Held
40,580
+1.8% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#196
of 844 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Lansforsakringar Fondforvaltning AB (publ) holds $191,892,065 across 12 Diagnostics & Research names. NTRA ranks #6 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
131,916 | $66,137,405 | |
| 2 | DHR |
Danaher Corp /De/
|
196,388 | $37,407,986 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
24,161 | $12,719,316 | |
| 4 | A |
Agilent Technologies, Inc.
|
88,456 | $11,749,610 | |
| 5 | WAT |
Waters Corp /De/
|
30,952 | $11,608,238 | |
| 6 | NTRA |
Natera, Inc.
This page
|
40,580 | $11,015,441 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
51,226 | $9,897,887 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
6,414 | $8,193,949 |
All Filings in NTRA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,015,441 | 40,580 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $7,974,801 | 39,876 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $9,266,232 | 40,448 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $6,255,616 | 38,862 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $6,565,346 | 38,862 | Shares | Sole | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||